HMGB1 and neoplasm: Liikanen et al., for instance, reported that combining oncolytic Ads 5/3-D24-GM-CSF with temozolomide (TMZ) reduced tumor development, promoted autophagy, and triggered ICD through increasing ATP secretion, CALR, and HMGB1 expression [86].